Akèy › Maladi Parkinson › New York › New York City
Etid klinik pou Maladi Parkinson nan New York City, NY
23 etid pou Maladi Parkinson ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Ap rekriteFaz 2
- Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York
- Columbia University, New York
Visual Hallucinations in Lewy Body Diseases
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NYU Langone Health, New York
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Ap rekriteFaz 2/3
- Site-005, New York
GBPDC: Gut-Brain in PD Consortium Master Protocol
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Columbia University, New York
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
Ap rekriteFaz 2
- Weill Cornell Medical College, New York
A Study of Buntanetap in Participants With PD
Ap rekriteFaz 2/3
- Mount Sinai Hospital, New York
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Ap rekriteFaz 2
- Vima Site #024, New York
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Ap rekriteFaz 2
- Joan and Sanford I. Weill Department of Medicine (Site #224), New York
- Mount Sinai School of Medicine (Site #209), New York
Parkinson's Foundation PD GENEration Genetic Registry
Ap rekriteEtid obsèvasyon
- Mount Sinai, New York
- Columbia University, New York
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Ap rekriteEtid obsèvasyon
- Northwell Health, New York
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Ap rekriteFaz 3
- Weill Cornell Medical College, New York
- Columbia University Medical Center, New York
Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NYU Langone Health, New York
Autoimmune Features of Neurodegenerative Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Columbia University Medical Center, New York
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Ap rekriteFaz 3
- Mount Sinai West - Neurology, New York
- New York Presbyterian/Weill Cornell Medical Center, New York
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
Ap rekrite
- Radial Midtown Manhattan, New York
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Beth Israel Medical Center, New York
- NYU Langone Health, New York
Natural History Study of Synucleinopathies
Ap rekriteEtid obsèvasyon
- NYU Medical Center, New York
Parkinson's Disease Biomarkers in Nerve Cells in the Gut
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Weill Cornell Medicine, New York
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
Ap rekriteFaz 1/2
- Cornell University Weill Medical College, New York
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Ap rekriteEtid obsèvasyon
- Weill Cornell Medicine, New York
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
Ap rekriteFaz 1/2
- New York Presbyterian Hospital-Columbia University Medical Center, New York
NYSCF Scientific Discovery Biobank
Ap rekriteEtid obsèvasyon
- New York Stem Cell Foundation Research Institute, New York
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
Ap rekriteFaz 1 bonè
- Teachers College, Columbia University, New York
Etid Maladi Parkinson nan lòt vil
- Boston, MA19 etid
- Cleveland, OH18 etid
- Minneapolis, MN17 etid
- Nashville, TN15 etid
- Philadelphia, PA14 etid
- San Francisco, CA14 etid
- New Haven, CT14 etid
- Charleston, SC13 etid
- Farmington Hills, MI13 etid
- Chicago, IL13 etid
- Miami, FL13 etid
- Aurora, CO12 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.